欧洲药品局(EMA)批准使用Ingelvac CircoFLEX®

　　EU - The European Medicines Agency (EMA) has granted the use of Boehringer Ingelheim’s Ingelvac CircoFLEX® during pregnancy and lactation in sows. The vaccine is registered worldwide for the protection of pigs against Porcine Circovirus Type 2 (PCV2) related diseases. Ingelvac CircoFLEX® reduces mortality, clinical signs and lesions associated with PCV2.Today, piglet vaccination is the global standard measure for the prevention of PCV2 related diseases in pigs; Ingelvac CircoFLEX® is the global market leader in this product segment.

　　欧盟——欧洲药品局(EMA)已经授予在孕期和母猪哺乳期使用勃林格殷格翰集团的Ingelvac CircoFLEX®。此疫苗是全球范围内注册的，保护猪免除猪圆环病毒2型(PCV2)相关疾病。Ingelvac CircoFLEX®减少死亡率、临床症状和与PCV2有关的病变。今天小猪接种PCV2疫苗，是全球范围的预防猪身上相关疾病的措施，Ingelvac CircoFLEX®是该产品的全球市场领导者。